170 related articles for article (PubMed ID: 2578770)
21. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
22. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
King GW; Halpin JJ; Smith RE; Batley F; Schuller DE
Cancer Treat Rep; 1979; 63(11-12):1735-8. PubMed ID: 93508
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.
Rowland KM; Taylor SG; Spiers AS; DeConti RC; O'Donnell MR; Showel J; Stott PB; Milner LM; Marsh JC
Cancer Treat Rep; 1986 Apr; 70(4):461-4. PubMed ID: 3698038
[TBL] [Abstract][Full Text] [Related]
24. Induction chemotherapy with methotrexate, bleomycin and hydroxyurea with or without cisplatin in advanced squamous cell carcinoma of the head and neck: a study of the Swiss Group for Clinical Cancer Research (SAKK).
Abele R; Honegger HP; Wolfensberger M; Grossenbacher R; Mermillod B; Cavalli F
Prog Clin Biol Res; 1985; 201():169-75. PubMed ID: 2419916
[No Abstract] [Full Text] [Related]
25. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin and 5-fluorouracil in recurrent head and neck cancer: results of an outpatient schedule.
Airoldi M; Pedani F; Brando V; Giordano C; Gabriele P
Chemioterapia; 1988 Apr; 7(2):127-9. PubMed ID: 3396116
[TBL] [Abstract][Full Text] [Related]
27. Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer.
Von Hoff DD; Alberts DS; Mattox DE; Coulthard S; Dana B; Manning M; Myers JW; Griffin CB
Cancer Clin Trials; 1981; 4(2):215-8. PubMed ID: 6166408
[TBL] [Abstract][Full Text] [Related]
28. [Side effects of peplomycin].
Araki Y; Tamura K; Seita M
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2446-50. PubMed ID: 2425749
[TBL] [Abstract][Full Text] [Related]
29. [Combination chemotherapy (BEAM regimen) for head and neck cancer].
Noguchi A; Inoue A; Kasai N; Uchida M
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2158-62. PubMed ID: 6194755
[TBL] [Abstract][Full Text] [Related]
30. [Adjuvant chemotherapy in advanced squamous cell carcinoma of the head and neck].
Zhou T; Zeng Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(3):171-3. PubMed ID: 8579878
[TBL] [Abstract][Full Text] [Related]
31. [CDDP-containing combination chemotherapy for advanced lung cancer].
Asamoto H; Hisa T; Sawano T; Sakai K; Kitamura S; Matsushita N; Kokura M; Satake H; Kawakami I
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2544-9. PubMed ID: 6210053
[TBL] [Abstract][Full Text] [Related]
32. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
Konami T; Wakabayashi Y; Kim T; Ishida A; Arai Y; Konishi T; Pak K; Takeuchi H; Tomoyoshi T; Watanabe J
Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy in advanced squamous cell carcinoma of the head and neck with methotrexate, bleomycin and cisplatin.
Hupperets PS; Van der Vegt SG; Bruaset I; Van den Broek P; Wagener DJ
Neth J Med; 1985; 28(9):352-5. PubMed ID: 2413380
[No Abstract] [Full Text] [Related]
34. [The significance of chemotherapy in oral cancer].
Uchida M; Kaneko S; Inoue A
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1781-8. PubMed ID: 2439015
[TBL] [Abstract][Full Text] [Related]
35. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
[TBL] [Abstract][Full Text] [Related]
36. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
[TBL] [Abstract][Full Text] [Related]
37. Sequential administration of methotrexate, cisplatin, and 5-fluorouracil in multimodal therapy for locally advanced head and neck cancer.
Vokes EE; Moran WJ; Awan AM; Schilsky RL; Goldman M; Sutton HG; Weichselbaum RR; Panje WR
NCI Monogr; 1988; (6):353-6. PubMed ID: 3352782
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
39. [Combination chemotherapy with peplomycin, cis-platinum and mitomycin C in gynecologic cancer].
Yasui Y; Suzumori K; Asai H; Yagami Y
Gan No Rinsho; 1985 Sep; 31(11):1415-21. PubMed ID: 2415720
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
Hussain M; Gadgeel S; Kucuk O; Du W; Salwen W; Ensley J
Cancer; 1999 Dec; 86(11):2364-9. PubMed ID: 10590379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
